Company

enVVeno Medical Corp

Headquarters: Irvine, CA, United States

Employees: 19

CEO: Mr. Robert A. Berman

NASDAQ: NVNO -6.65%

Detailed Description

enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based devices to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and works as a replacement venous valve to reduce reflux and venous hypertension, as well as to restore proper directional blood flow back to the heart. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

enVVeno Medical Corp has the following listings and related stock indices.


Stock: NASDAQ: NVNO wb_incandescent

Details

Headquarters:

70 Doppler

Irvine, CA 92618

United States

Phone: 949 261 2900